Eric L. Chang, MD is an internationally recognized authority in radiotherapeutic evaluation and the management of patients.
Chang established the first Gamma Knife radiosurgery program at MD Anderson and served as the director of the CNS Stereotactic Radiation Program comprising the Gamma Knife program and the Steretoactic Body Radiation Therapy program for spine. He has been listed in the Best Doctors Directory. Chang has been selected as a plenary speaker for past meetings of ASTRO and the American Association for Neurological Surgeons.
About Eric L. Chang, MD, FASTRO
Chang is board certified by the American Board of Radiology in radiation oncology and specializes in the radiotherapeutic evaluation and management of patients with tumors of the central nervous system. He notably led a phase III randomized controlled trial on brain metastasis published in the Lancet Oncology 2009 which has changed the practice patterns for metastatic brain disease.
Chang’s primary research focus revolves around tumors of the central nervous system. His current clinical research activities include post-resection cavity radiosurgery, meta-analysis of randomized trials of radiosurgery with or without whole brain irradiation, ASTRO Glioblastoma Treatment Guideline Document and ACR Appropriateness Criterion for Brain and Bone Metastases.